Therapy to prevent bone loss and restore sexual function in women

About the study

We are assessing therapy to prevent bone loss and restore sexual function in women with primary ovarian insufficiency. 

This is a 12-month study using topical testosterone cream applied to the skin on women aged under 45 years with primary ovarian insufficiency (complete loss of ovarian function before age 40).

Your participation will involve 5 visits with blood collection and bone density scans.


Women’s Health Research Program, Monash University

Ethics Approval

This study is approved by Monash University Human Research  Ethics Committee


To participate or for further information
Please contact:
Women’s Health Research Program
Monash University
Phone: (03) 99030827
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
The Women’s Health Research Program

pdfPOI_Study_Flyer_v3_20_Oct_2021133.97 KB

Monash University


[V3 dated 20.07.2021]

Content created October 2021